https://www.selleckchem.com/products/sr10221.html
Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was declared a pandemic by WHO in 2020. Obesity and other components of the metabolic syndrome may aggravate the severity of COVID-19. Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome. The aim of this study was to investigate a possible association between MAFLD and COVID-19 severity. We performed a retrospective, case-control study, enrolling 71 consecutive COVID-19 patients who were divided into two groups acco
Like
Comment
Share
